Süper İlaç Grubu specializes in the production of steroidal and peptide raw materials and finished products. We have established an integrated resource service platform encompassing R&D, manufacturing, and sales, dedicated to connecting global partners with quality products, reliable supply, and professional support. Through continuous innovation and collaboration, we serve as a trusted pharmaceutical partner to over 300 customers worldwide, delivering sustainable and technologically advanced steroidal and peptide products and services that benefit millions of patients globally.
As a professional GMP manufacturer of steroidal ve peptit farmasötikleri, we are committed to providing exceptional global distribution services for a wide range of products, including Active Pharmaceutical Ingredients (APIs), Finished Dosage Forms (FDFs), and CDMO solutions. By combining deep industry expertise with tailored international trading services, Superpharma Group creates significant value for our global pharmaceutical partners, supporting their long-term growth and success.
The company was officially established in October 2020
Obtained a drug production license in March 2022
Mayıs 2023’te GMP sertifikasını aldı
The second-phase factory has been completed and put into operation in October 2024
At Superpharma Group, our corporate culture is rooted in integrity, innovation, collaboration and excellence. We are committed to advancing pharmaceutical science through continuous innovation, delivering high-quality products with uncompromising responsibility, and fostering long-term partnerships built on trust. Guided by a global vision, we embrace diversity, encourage teamwork, and strive to create sustainable value for our customers, employees, and society.
To be a global leader in the pharmaceutical industry, delivering high-quality APIs that improve health and well-being worldwide.
To manufacture and supply high-quality APIs through innovation, excellence, and a commitment to customer satisfaction. We aim to achieve this by:
